Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Matthay KK, Weiss B, Villablanca JG. et al.
Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.

J Nucl Med 2012;
53 (07) 1155-1163

Bibliographische Angaben herunterladen

Aufrufen in: